Lung cancer trials in China

In China 1143 Also abroad 2747

1,143 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
Where
Hefei
Age
18 years and over
People
12
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT07195084
Phase 2Not yet taking people in China
Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Where
Sichuan
Age
18 years to 75 years
People
33
Run by
Sichuan University
See details and how to joinNCT07501169
No phaseTaking people
Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
Where
Shanghai
Age
18 years and over
People
204
Run by
Shanghai Chest Hospital
See details and how to joinNCT07515027
Phase 3Taking people
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
536
Run by
Akeso
See details and how to joinNCT06928389
Phase 2Taking people
A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
200
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07241767
Phase 2Not yet taking people in China
Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
Where
Shanghai
Age
18 years and over
People
45
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07517640
No phaseEnrolling by invitation
Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen
Where
Jinan
Age
18 years to 75 years
People
10
Run by
Jinan Central Hospital
See details and how to joinNCT07514728
Phase 1/2Taking people
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Where
Changchun, Changsha, Chengdu, Nanjing, Shanghai, Shenyang, Wuxi, Zhengzhou
Age
18 years and over
People
1,000 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05785741
Phase 3Taking people
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Where
Chongqing, Guangzhou
Age
18 years and over
People
220
Run by
Sun Yat-sen University
See details and how to joinNCT07481786
Phase 2Not yet taking people in China
Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC
Where
Changsha
Age
18 years to 70 years
People
50
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT06706219
No phaseTaking people
FL-261 Imaging for Cancer Diagnosis and Staging
Where
Wuhan
Age
18 years and over
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07510321
Phase 2Not yet taking people in China
A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
Where
Tianjin
Age
18 years to 75 years
People
48
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07510594
Phase 3Taking people
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
Where
Changsha, Chenzhou, Hengyang, Yueyang
Age
18 years and over
People
121
Run by
Hunan Cancer Hospital
See details and how to joinNCT06840704
No phaseTaking people
Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
Where
Guangzhou
Age
18 years to 75 years
People
42
Run by
Guangzhou University of Traditional Chinese Medicine
See details and how to joinNCT07348965
No phaseTaking people
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Where
Beijing
Age
18 years and over
People
80
Run by
Peking University People's Hospital
See details and how to joinNCT07487883
Phase 1/2Taking people
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
Where
Xi'an
Age
18 years to 75 years
People
20
Run by
Tang-Du Hospital
See details and how to joinNCT07354061
No phaseTaking people
FAP-targeted PET/NIR in Lung Malignant Tumors
Where
Beijing
Age
18 years to 70 years
People
200
Run by
Peking University People's Hospital
See details and how to joinNCT07498933
Phase 2Taking people
Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer
Where
Tianjin
Age
18 years to 75 years
People
74
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07505173
No phaseTaking people
Large Language Models Assist in Tumor MDT
Where
Guangzhou
Age
25 years to 33 years
People
60
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07504367
Phase 1Taking people
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Where
Guangzhou
Age
18 years to 75 years
People
288
Run by
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT06868732
No phaseTaking people
Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
Where
Shanghai
Age
18 years to 80 years
People
210
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07134660
Phase 2Taking people
Durvalumab as Consolidation for Patients LS-SCLC
Where
Wuhan, Zhengzhou
Age
18 years and over
People
100
Run by
Qian Chu
See details and how to joinNCT07055581
No phaseTaking people
A Retrospective Real-World Study Based on RATIONALE-307
Where
Beijing
People
109
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07478809
Phase 2Not yet taking people in China
Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients
Where
Shanghai
Age
18 years to 80 years
People
54
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07493980
No phaseEnrolling by invitation
Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?
Where
Beijing
Age
18 years and over
People
44
Run by
Peking University People's Hospital
See details and how to joinNCT07494006